B2M and Miyoshi myopathy: Furthermore, multivariate Cox regression models highlighted the poor treatment outcome of the MM patients with miR-221/222 loss, independently of the established disease markers and patients’ clinical data, including response to 1st-line therapy, R-ISS stage, high-risk cytogenetics, HDM/ASCT, B2M, LDH and creatinine levels, age and gender.